Breast Cancer Clinical Trials in Lyon

20 recruitingLyon, France

Showing 120 of 20 trials

Recruiting
Phase 3

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib

Breast Cancer
UNICANCER3,902 enrolled70 locationsNCT07237256
Recruiting
Phase 1Phase 2

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Breast CancerSolid Tumors, Adult
Eli Lilly and Company720 enrolled67 locationsNCT05768139
Recruiting
Phase 3

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

Breast Cancer
AstraZeneca625 enrolled315 locationsNCT06103864
Recruiting
Not Applicable

Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.

Breast Cancer
UNICANCER1,508 enrolled3 locationsNCT07120087
Recruiting
Not Applicable

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

Breast Cancer
Institut Claudius Regaud120 enrolled25 locationsNCT05378204
Recruiting

Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

Breast CancerBreast Cancer SurgeryMedico-economic Impact
Centre Leon Berard772 enrolled7 locationsNCT06906601
Recruiting
Phase 2

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting

REBECCA Real-world Early BrEast CanCer mAnagement

Breast Cancer
AstraZeneca126 enrolled44 locationsNCT06856343
Recruiting
Not Applicable

Streamlined Geriatric and Oncological Evaluation Based On IC Technology

Breast CancerLung CancerComorbidities and Coexisting Conditions
Institut Bergonié720 enrolled10 locationsNCT05720910
Recruiting
Phase 2

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

Breast Cancer
BicycleTx Limited66 enrolled39 locationsNCT06840483
Recruiting
Phase 1Phase 2

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

Breast CancerMetastatic Breast Cancer
Stemline Therapeutics, Inc.435 enrolled118 locationsNCT05563220
Recruiting
Phase 3

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Breast Cancer
Greenwich LifeSciences, Inc.750 enrolled161 locationsNCT05232916
Recruiting
Not Applicable

Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

Breast CancerCognitive Dysfunction
Centre Francois Baclesse300 enrolled25 locationsNCT06027632
Recruiting
Phase 1

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Breast CancerAdvanced CancerAdvanced Solid Tumors+1 more
OnKure, Inc.200 enrolled34 locationsNCT06239467
Recruiting
Not Applicable

Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request

Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle264 enrolled9 locationsNCT06415266
Recruiting
Not Applicable

Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1

Breast Cancer
International Agency for Research on Cancer60 enrolled1 locationNCT06305117
Recruiting
Not Applicable

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction

Breast CancerCapsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle250 enrolled9 locationsNCT04342546
Recruiting
Not Applicable

Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy

Breast Cancer
Hospices Civils de Lyon100 enrolled1 locationNCT06299202
Recruiting
Not Applicable

Spa Therapy for Upper or Lower Limb Lymphoedema

Breast CancerProstate CancerLymphoma+3 more
Association Francaise pour la Recherche Thermale160 enrolled13 locationsNCT03580109
Recruiting
Not Applicable

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Breast CancerGastric CancerProstate Cancer+5 more
Hospices Civils de Lyon410 enrolled17 locationsNCT03787056